journal article·2013-05-28Open access

Peptide Dendrimer/Lipid Hybrid Systems Are Efficient DNA Transfection Reagents: Structure–Activity Relationships Highlight the Role of Charge Distribution Across Dendrimer Generations

Albert Kwok, Gabriela A. Eggimann, Jean-Louis Reymond, Tamis Darbre, Florian Hollfelder

ACS Nano· Volume 7· Issue 5

Abstract

Efficient DNA delivery into cells is the prerequisite of the genetic manipulation of organisms in molecular and cellular biology as well as, ultimately, in nonviral gene therapy. Current reagents, however, are relatively inefficient, and structure-activity relationships to guide their improvement are hard to come by. We now explore peptide dendrimers as a new type of transfection reagent and provide a quantitative framework for their evaluation. A collection of dendrimers with cationic and hydrophobic amino acid motifs (such as KK, KA, KH, KL, and LL) distributed across three dendrimer generations was synthesized by a solid-phase protocol that provides ready access to dendrimers in milligram quantities. In conjunction with a lipid component (DOTMA/DOPE), the best reagent, G1,2,3-KL ((LysLeu)8(LysLysLeu)4(LysLysLeu)2LysGlySerCys-NH2), improves transfection by 6-10-fold over commercial reagents under their respective optimal conditions. Emerging structure-activity relationships show that dendrimers with cationic and hydrophobic residues distributed in each generation are transfecting most efficiently. The trigenerational dendritic structure has an advantage over a linear analogue worth up to an order of magnitude. The success of placing the decisive cationic charge patterns in inner shells rather than previously on the surface of macromolecules suggests that this class of dendrimers significantly differs from existing transfection reagents. In the future, this platform may be tuned further and coupled to cell-targeting moieties to enhance transfection and cell specificity.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Immunotherapy and Immune Responses

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge CB2 1GA, United Kingdom,

Department of Chemistry & Biochemistry, University of Bern, Freiestrasse 3, CH-3012 Bern, Switzerland

References (98)

Show source-provided references
1. Edelstein M. L. · J. Gene Med. · 2007 · 9 · 83310.1002/jgm.1100 ↗
2. Morille M. · Biomaterials · 2008 · 29 · 347710.1016/j.biomaterials.2008.04.036 ↗
3. Al-Dosari M. S. · AAPS J. · 2009 · 11 · 67110.1208/s12248-009-9143-y ↗
4. Park T. G. · Adv. Drug Delivery Rev. · 2006 · 58 · 46710.1016/j.addr.2006.03.007 ↗
5. Wasungu L. · J. Controlled Release · 2006 · 116 · 25510.1016/j.jconrel.2006.06.024 ↗
6. Sheridan C. · Nat. Biotechnol. · 2011 · 29 · 12110.1038/nbt.1769 ↗
7. Mintzer M. A. · Chem. Rev. · 2009 · 109 · 25910.1021/cr800409e ↗
8. Lufino M. M. · Mol. Ther. · 2008 · 16 · 152510.1038/mt.2008.156 ↗
9. Pack D. W. · Nat. Rev. Drug Discovery · 2005 · 4 · 58110.1038/nrd1775 ↗
10. Guo X. · Acc. Chem. Res. · 2012 · 45 · 97110.1021/ar200151m ↗
11. Behr J. P. · Acc. Chem. Res. · 2012 · 45 · 98010.1021/ar200213g ↗
12. Kostarelos K. · Chem. Soc. Rev. · 2005 · 34 · 97010.1039/b307062j ↗
13. Miller A. D. · Angew. Chem., Int. Ed. · 1998 · 37 · 176810.1002/(SICI)1521-3773(19980803)37:13/14<1768::AID-ANIE1768>3.0.CO;2-4 ↗
14. Kirby A. J. · Angew. Chem., Int. Ed. · 2003 · 42 · 144810.1002/anie.200201597 ↗
15. Findeis M. A. · 2001 · 6510.1385/1592591396 ↗
16. Ewert K. K. · Top. Curr. Chem. · 2010 · 296 · 19110.1007/128_2010_70 ↗
17. Sun S. · Bioconjugate Chem. · 2012 · 23 · 13510.1021/bc200572w ↗
18. De Laporte L. · Biomaterials · 2006 · 27 · 94710.1016/j.biomaterials.2005.09.036 ↗
19. Neu M. · J. Gene Med. · 2005 · 7 · 99210.1002/jgm.773 ↗
20. Merkel O. M. · Acc. Chem. Res. · 2012 · 45 · 96110.1021/ar200110p ↗
21. Boussif O. · Proc. Natl. Acad. Sci. U.S.A. · 1995 · 92 · 729710.1073/pnas.92.16.7297 ↗
22. Hoyer J. · Acc. Chem. Res. · 2012 · 45 · 104810.1021/ar2002304 ↗
23. Harbottle R. P. · Hum. Gene Ther. · 1998 · 9 · 103710.1089/hum.1998.9.7-1037 ↗
24. Luo K. · J. Controlled Release · 2011 · 155 · 7710.1016/j.jconrel.2010.10.006 ↗
25. Wolfert M. A. · Gene Ther. · 1996 · 3 · 269
26. Ramsay E. · Int. J. Pharm. · 2000 · 210 · 9710.1016/S0378-5173(00)00571-8 ↗
27. Nayvelt I. · Biomacromolecules · 2007 · 8 · 47710.1021/bm0605863 ↗
28. Naik R. J. · J. Biol. Chem. · 2011 · 286 · 1898210.1074/jbc.M111.227793 ↗
29. Mann A. · Mol. Pharmaceutics · 2011 · 8 · 172910.1021/mp2000814 ↗
30. Welser K. · Mol. Pharmaceutics · 2013 · 10 · 12710.1021/mp300187t ↗
31. Mintzer M. A. · Chem. Soc. Rev. · 2010 · 40 · 17310.1039/B901839P ↗
32. Kukowska-Latallo J. F. · Proc. Natl. Acad. Sci. U.S.A. · 1996 · 93 · 489710.1073/pnas.93.10.4897 ↗
33. Braun C. S. · J. Pharm. Sci. · 2005 · 94 · 42310.1002/jps.20251 ↗
34. Navarro G. · Nanomedicine · 2009 · 5 · 28710.1016/j.nano.2008.12.007 ↗
35. Zhang X. Q. · Biomacromolecules · 2005 · 6 · 34110.1021/bm040060n ↗
36. Choi J. S. · J. Controlled Release · 2004 · 99 · 44510.1016/j.jconrel.2004.07.027 ↗
37. Kim T. I. · J. Controlled Release · 2009 · 136 · 13210.1016/j.jconrel.2009.01.028 ↗
38. Tang M. X. · Bioconjugate Chem. · 1996 · 7 · 70310.1021/bc9600630 ↗
39. Bonner D. K. · Bioconjugate Chem. · 2011 · 22 · 151910.1021/bc200059v ↗
40. Green J. J. · Methods Mol. Biol. · 2009 · 480 · 5310.1007/978-1-59745-429-2_4 ↗
41. Zinselmeyer B. H. · Pharm. Res. · 2002 · 19 · 96010.1023/A:1016458104359 ↗
42. Kim T. I. · Biomaterials · 2007 · 28 · 206110.1016/j.biomaterials.2006.12.013 ↗
43. Schatzlein A. G. · J. Controlled Release · 2005 · 101 · 24710.1016/j.jconrel.2004.08.024 ↗
44. Ohsaki M. · Bioconjugate Chem. · 2002 · 13 · 51010.1021/bc015525a ↗
45. Van Vliet L. D. · ChemBioChem · 2008 · 9 · 196010.1002/cbic.200800003 ↗
46. Takahashi T. · Bioconjugate Chem. · 2007 · 18 · 116310.1021/bc070014v ↗
47. Takahashi T. · Bioconjugate Chem. · 2003 · 14 · 76410.1021/bc025663f ↗
48. Barnard A. · J. Am. Chem. Soc. · 2011 · 133 · 2028810.1021/ja2070736 ↗
49. Okuda T. · Biomaterials · 2004 · 25 · 53710.1016/S0142-9612(03)00542-8 ↗
50. Rudolph C. · J. Biol. Chem. · 2003 · 278 · 1141110.1074/jbc.M211891200 ↗
51. Luo K. · Biomaterials · 2012 · 33 · 491710.1016/j.biomaterials.2012.03.030 ↗
52. Kono K. · Bioconjugate Chem. · 2005 · 16 · 20810.1021/bc049785e ↗
53. Jevprasesphant R. · Pharm. Res. · 2003 · 20 · 154310.1023/A:1026166729873 ↗
54. Leng Q. · Nucleic Acids Res. · 2005 · 33 · E4010.1093/nar/gni040 ↗
55. Zuhorn I. S. · Eur. Biophys. J. · 2007 · 36 · 34910.1007/s00249-006-0092-4 ↗
56. Demeneix B. · Curr. Gene Ther. · 2004 · 4 · 44510.2174/1566523043345940 ↗
57. Demeneix B. · Adv. Genet. · 2005 · 53 · 217
58. Lv H. · J. Controlled Release · 2006 · 114 · 10010.1016/j.jconrel.2006.04.014 ↗
59. Hafez I. M. · Gene Ther. · 2001 · 8 · 118810.1038/sj.gt.3301506 ↗
60. Felgner J. H. · J. Biol. Chem. · 1994 · 269 · 255010.1016/S0021-9258(17)41980-6 ↗
61. Mcgregor C. · J. Am. Chem. Soc. · 2001 · 123 · 621510.1021/ja005681c ↗
62. Siegwart D. J. · Proc. Natl. Acad. Sci. U.S.A. · 2011 · 108 · 1299610.1073/pnas.1106379108 ↗
63. Merkel O. M. · Mol. Pharmaceutics · 2010 · 7 · 96910.1021/mp100101s ↗
64. Jones S. P. · Chemistry · 2010 · 16 · 451910.1002/chem.200902546 ↗
65. Kim J. B. · J. Controlled Release · 2006 · 114 · 11010.1016/j.jconrel.2006.05.011 ↗
66. Jevprasesphant R. · Int. J. Pharm. · 2003 · 252 · 26310.1016/S0378-5173(02)00623-3 ↗
67. Maillard N. · Nat. Protoc. · 2009 · 4 · 13210.1038/nprot.2008.241 ↗
68. Maillard N. · J. Comb. Chem. · 2009 · 11 · 66710.1021/cc9000289 ↗
69. Darbre T. · Acc. Chem. Res. · 2006 · 39 · 92510.1021/ar050203y ↗
70. Sommer P. · ChemBioChem · 2008 · 9 · 68910.1002/cbic.200700606 ↗
71. Delort E. · J. Am. Chem. Soc. · 2004 · 126 · 1564210.1021/ja044652p ↗
72. Johansson E. M. · Chem. Biol. · 2008 · 15 · 124910.1016/j.chembiol.2008.10.009 ↗
73. Johansson E. M. · Bioorg. Med. Chem. · 2010 · 18 · 658910.1016/j.bmc.2010.04.026 ↗
74. Godbey W. T. · J. Controlled Release · 1999 · 60 · 14910.1016/S0168-3659(99)00090-5 ↗
75. Yamagata M. · Bioorg. Med. Chem. · 2007 · 15 · 52610.1016/j.bmc.2006.09.033 ↗
76. 10.1016/j.jconrel.2013.01.01910.1016/j.jconrel.2013.01.019 ↗
77. Huang R. Q. · FASEB J. · 2007 · 21 · 111710.1096/fj.06-7380com ↗
78. Kedika B. · J. Med. Chem. · 2010 · 54 · 54810.1021/jm100704u ↗
79. Grosse S. M. · FASEB J. · 2010 · 24 · 230110.1096/fj.09-144220 ↗
80. Tagalakis A. D. · Biomaterials · 2010 · 32 · 137010.1016/j.biomaterials.2010.10.037 ↗
81. Hoekstra D. · Biochem. Soc. Trans. · 2007 · 35 · 6810.1042/BST0350068 ↗
82. Kwok A. · Nanomedicine · 2011 · 7 · 21010.1016/j.nano.2010.07.005 ↗
83. Wang Y. · Biomacromolecules · 2009 · 10 · 61710.1021/bm801333s ↗
84. Demeneix B. · Adv. Drug Delivery Rev. · 1998 · 30 · 8510.1016/S0169-409X(97)00109-9 ↗
85. Merdan T. · Adv. Drug Delivery Rev. · 2002 · 54 · 71510.1016/S0169-409X(02)00046-7 ↗
86. Fischer W. · Top. Curr. Chem. · 2010 · 296 · 9510.1007/128_2010_64 ↗
87. Merkel O. M. · Bioconjugate Chem. · 2009 · 20 · 179910.1021/bc900243r ↗
88. Albertazzi L. · Biomacromolecules · 2012 · 13 · 408910.1021/bm301384y ↗
89. Amir E. · Chem. Commun. · 2012 · 48 · 483310.1039/c2cc31188g ↗
90. Liu X. · Bioconjugate Chem. · 2011 · 22 · 246110.1021/bc200275g ↗
91. Hsu S. C. · J. Biol. Chem. · 2007 · 282 · 1043210.1074/jbc.M610014200 ↗
92. Carlisle R. C. · Mol. Ther. · 2001 · 4 · 47310.1006/mthe.2001.0472 ↗
93. Benimetskaya L. · Bioconjugate Chem. · 2002 · 13 · 17710.1021/bc010068j ↗
94. Akita H. · J. Gene Med. · 2006 · 8 · 19810.1002/jgm.839 ↗
95. Hancock W. S. · Anal. Biochem. · 1976 · 71 · 26010.1016/0003-2697(76)90034-8 ↗
96. Ruiz-Gayo M. · J. Org. Chem. · 1993 · 58 · 631910.1021/jo00075a027 ↗
97. Nagata K. · Peptides · 1992 · 13 · 65310.1016/0196-9781(92)90169-4 ↗
98. Hufnagel H. · Mol. Ther. · 2009 · 17 · 141110.1038/mt.2009.121 ↗